CClinicalTrials.gg
CompletedNCT03625492FABULUSUpdated Nov 14, 2019

Fluids Affecting Bladder Urgency and Lower Urinary Symptoms

An interventional study of Reducing Potentially Irritating Beverages and Adopting the USDA Healthy Eating Habits in Overactive Bladder, Urinary Urgency and Urinary Bladder, Overactive, sponsored by University of Michigan. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-14.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study evaluates whether eliminating certain ingredients (caffeine, alcohol, artificial sweeteners, acidic juices) consumed in beverages reduces bladder symptoms of urinary frequency and urgency. Women with overactive bladder will be recruited. Half of these women will receive instructions to replace beverages containing these ingredients with beverages such as water or milk. The other half of participants will receive instructions on following the United States Department of Agriculture guidelines on healthy eating.

Read the detailed description

It is commonly believed that it is better for women's bladders if intake of certain beverages is eliminated. Advice is given to women with frequency/urgency symptoms to avoid coffee or tea, sodas or pop, or any other drinks that contain alcohol, caffeine, artificial sweeteners or high acidic content. Although the investigators do not know the direct cause and effect of consuming beverages with these ingredients, there might be reduction in "irritating" sensation to toilet often because of urgency if the beverages with these ingredients are replaced by "non-irritating" beverages.

02

Conditions studied

  • Overactive Bladder
  • Urinary Urgency
  • Urinary Bladder, Overactive
  • Urinary Incontinence, Urge
  • Caffeine
  • Alcohol Drinking
  • Lower Urinary Tract Symptoms

Keywords

  • artificial sweeteners
  • caffeine
  • alcohol drinking
  • urinary urgency
  • overactive bladder
  • urinary incontinence, urge
  • lower urinary tract symptoms
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 65 is close to the median of 66 across 1,011 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female
  • Daily intake of at least 16 oz. of potentially irritating beverages, defined as drinks that are caffeinated, artificially sweetened, citric/acidic, or alcoholic beverages
  • Daily intake of at least 32 oz. of total beverages
  • At least two of the following three qualifications: urinating greater than on average seven times during waking hours on 3-day diary, urinating routinely more than two times at night, answering "yes" to experiencing frequent, strong feelings of urgency to empty the bladder.

Exclusion criteria

Exclusion Criteria:

  • Men
  • History of diabetes, spinal cord injury, multiple sclerosis, muscular dystrophy, cerebral palsy, dementia or Alzheimer's or stroke
  • Currently pregnant or within one year of delivery
  • Currently report symptoms of pain with urination or frequent urinary tract infections
  • Uses diuretic medications, currently taking medication prescribed for bladder symptoms or have had surgery for incontinence with the last 12 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    Reduce Potentially Irritating Beverages

    This group will receive a 7 minute video teaching participants to replace beverages that include caffeine, alcohol, artificial sweeteners, or acidic juices with equal volume intake of water, milk, or other beverages that do not have these ingredients in them.

    Behavioral: Reducing Potentially Irritating Beverages

  • Active comparator
    Adopt Healthy Eating Habits

    This group will receive a 7 minute video teaching them the USDA guidelines for healthy eating.

    Behavioral: Adopting the USDA Healthy Eating Habits

Interventions

  • BehavioralReducing Potentially Irritating Beverages

    This group will receive a 7 minute video teaching participants to replace beverages that include caffeine, alcohol, artificial sweeteners, or acidic juices with equal volume intake of water, milk, or other beverages that do not have these ingredients in them.

  • BehavioralAdopting the USDA Healthy Eating Habits

    This group will receive a 7 minute video teaching them the USDA guidelines for healthy eating.

06

What researchers measure

Primary outcomes

  1. Urination frequency on 3-day bladder diary

    Average number of times urinated per day on 3-day bladder diary

    Time frame: 2-weeks

Secondary outcomes

  1. Volume of urine per toileting event

    Average volume of urine per day with each toileting event on 3-day bladder diary

    Time frame: 2-weeks

  2. Daily urination urgency symptoms (Adapted from Bower et al 2001)

    The adapted question reads, "Typically, when you needed to go to the bathroom today you could..." with the five potential responses ranging from "make the urge go away" to "already feel the urine coming out." Urgency will be measured as the mean reported score for each three-day time period for the perception of bladder fullness questionnaires.

    Time frame: 2-weeks

  3. Perception of bladder fullness relative to urination delay ability (DeWachter, 2003)

    On 3-day diary, participants will be asked to indicate their perception of bladder fullness when they urinated that day: "no bladder sensation," "urinating could easily be delayed for more than 30-60 minutes," "urinating could only be delayed for 30 minutes," "urinating could only be delayed for 5 minutes" and "immediate urinating will be mandatory and/or fear of leakage."

    Time frame: 2-weeks

  4. Bother associated with bladder symptoms (Coyne 2002)

    The investigators will use only the "bother" questions of this larger Questionnaire about bladder symptoms. We modified the original think-back period of 4-weeks to instead think back to "the past 3 days" to characterize the bother of bladder symptoms under the varying conditions of each specific intervention period. Bother will be measured on the final day on the bottom of each of the 3-day diaries.

    Time frame: 2-months

  5. Urination frequency on 3-day diary (longer-term effect)

    Average number of times urinated per day on 3-day bladder diary

    Time frame: 2-months

07

Study locations

1 site
  • University of Michigan School of Nursing
    Ann Arbor, Michigan 48109, United States
08

References and documents

Publications

  • Bower WF, Moore KH, Adams RD. A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol. 2001 Dec;166(6):2420-2. PubMed 11696802 ↗
  • Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002 Sep;11(6):563-74. doi: 10.1023/a:1016370925601. PubMed 12206577 ↗
  • De Wachter S, Wyndaele JJ. Frequency-volume charts: a tool to evaluate bladder sensation. Neurourol Urodyn. 2003;22(7):638-42. doi: 10.1002/nau.10160. PubMed 14595606 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03625492
Lead sponsor
University of Michigan
Collaborators
Blue Cross Blue Shield of Michigan Foundation, Arbor Research Collaborative for Health
Responsible party
Janis Miller (Professor, University of Michigan) — Principal investigator
First posted
Aug 10, 2018
Start date
Aug 7, 2018
Primary completion
Sep 17, 2019
Completion
Sep 17, 2019
Last update
Nov 14, 2019

Study contacts

Janis M Miller, PhD
principal investigator · University of Michigan
Megan O Schimpf, MD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion